This trial will enroll patients that have been diagnosed with minor stroke, which has
occurred within the past 6 hours. TRUST is a prospective multicenter, randomized,
blinded-endpoint study to evaluate the efficacy and safety of Urokinase Thrombolysis for
patients with minor stroke.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Beijing Tiantan Hospital General Hospital of Shenyang Military Region Shanghai 10th People's Hospital